Agenus Inc.

NASDAQ:AGEN

4.8 (USD) • At close June 23, 2025
Bedrijfsnaam Agenus Inc.
Symbool AGEN
Munteenheid USD
Prijs 4.8
Beurswaarde 131,600,640
Dividendpercentage 0%
52-weken bereik 1.38 - 18.74
Industrie Biotechnology
Sector Healthcare
CEO Dr. Garo H. Armen Ph.D.
Website https://www.agenusbio.com

An error occurred while fetching data.

Over Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon

Vergelijkbare Aandelen

Accolade, Inc. logo

Accolade, Inc.

ACCD

7.02 USD

IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYA

21.42 USD

Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc.

INO

1.93 USD

MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXG

5.94 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

13 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

40.6 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

9.79 USD

ADMA Biologics, Inc. logo

ADMA Biologics, Inc.

ADMA

17.87 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)